Aclaris Therapeutics nets $70.5mm in FOPO

15:40 EDT 18 Aug 2017 | Elsevier Business Intelligence

Aclaris Therapeutics Inc. (aesthetic dermatology) netted $70.5mm through the public offering of 3.26mm shares at $23.02. The ...

Original Article: Aclaris Therapeutics nets $70.5mm in FOPO


More From BioPortfolio on "Aclaris Therapeutics nets $70.5mm in FOPO"

Quick Search


Relevant Topics

Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...